Skip to records

Therapeutics

229Aging Biotech
100 of 229 records

VNA-318

Source date not recordedAnalyse record ↗

Investigational brain-penetrant small molecule designed to induce mitophagy for early-stage CNS and neurodegenerative disorders.

Modality
oral small molecule
Availability (US)
Phase 1 clinical development
Biomarkers
mitophagy target engagement; pharmacokinetic and pharmacodynamic measures
Hallmark targeted
mitochondrial dysfunction, mitophagy, proteostasis
Kind
investigational drug
Clinical trials
VNA-318-01